Basics Oragenics Inc. Oragenics Inc is a biopharmaceutical company which engages in the discovery, development and commercialization of technologies associated with oral health, broad spectrum antibiotics and other general health benefits. IPO Date: March 1, 2004 Sector: Healthcare Industry: Biotech Market Cap: $3.68M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.41% Avg Daily Range (30 D): $0.03 | 2.83% Avg Daily Range (90 D): $0.04 | 2.96% Institutional Daily Volume Avg Daily Volume: 1.52M Avg Daily Volume (30 D): .04M Avg Daily Volume (90 D): .1M Trade Size Avg Trade Size (Sh.): 526 Avg Trade Size (Sh.) (30 D): 218 Avg Trade Size (Sh.) (90 D): 241 Institutional Trades Total Inst.Trades: 14 Avg Inst. Trade: $.83M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $.67M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: .38K     News Apr 9, 2025 @ 12:58 PM Oragenics, Inc. Announces Health and Disability Et... Source: N/A Aug 16, 2024 @ 8:30 PM Oragenics, Inc. Provides Update on its Drug Intend... Source: Oragenics, Inc. Jul 22, 2024 @ 8:58 PM Oragenics delays 2023 Annual Meeting - Investing.c... Source: Natashya Angelica Jun 27, 2024 @ 12:30 PM Oragenics Develops Automated Intranasal Device for... Source: Oragenics Jun 26, 2024 @ 8:47 PM Oragenics, Inc. Announces Closing of Public Offeri... Source: Oragenics Financials   TTM Q3 2025 Q2 2025 Basic EPS $94.61 $-1.96 $-3.1 Diluted EPS $94.61 $-1.96 $-3.1 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -10.9M $ -3.07M $ -2.27M Operating Income / Loss $ -10.22M $ -3.12M $ -1.71M Cost of Revenue $ $ $ Net Cash Flow $ M $ M $ M PE Ratio 0.01     Splits Jun 03, 2025:   1:30 Jan 23, 2023:   1:60 Jan 22, 2018:   1:10 Sep 28, 2010:   1:20